Champions Oncology Inc (CSBR)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$5.22-1.14%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · CSBR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Apr 2026 | Apr 2025 | Apr 2024 | Apr 2023 | Apr 2022 | Apr 2021 | Apr 2020 | Apr 2019 | Apr 2018 | Apr 2017 | Apr 2016 | Apr 2015 | Apr 2014 | Apr 2013 | Apr 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||||||
| Revenues | 59.4 | 59.4 | 56.9 | 50.2 | 53.9 | 49.1 | 41.0 | 32.1 | 27.1 | — | — | — | — | — | — | — |
| Cost of Revenues | 30.9 | 30.9 | 28.4 | 29.4 | 29.5 | 23.6 | 21.4 | 17.0 | — | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||||||
| R&D Expenses | 9.1 | 9.1 | 6.8 | 9.5 | 11.5 | 9.4 | 7.2 | 5.9 | 4.8 | 4.4 | 4.3 | 4.2 | 4.8 | 2.3 | 1.9 | 2.9 |
| Operating Income | (1.1) | (1.1) | 4.6 | (7.4) | (5.3) | 0.6 | 0.4 | (1.9) | 0.3 | (1.4) | (6.8) | (10.3) | (13.2) | (6.3) | (6.2) | (9.1) |
| Earnings from Continuing Operations | ||||||||||||||||
| Other Non-Operating Income / Expenses | — | — | — | — | — | — | — | — | (0.0) | (0.1) | (0.1) | (0.0) | 0.2 | (1.1) | (0.1) | 0.4 |
| EBT, Incl. Unusual Items | (0.9) | (0.9) | 4.6 | (7.3) | (5.3) | 0.6 | 0.4 | (2.0) | 0.2 | (1.4) | (6.9) | (10.4) | (13.0) | (7.4) | (6.3) | (8.7) |
| Income Tax Expense | 0.2 | 0.2 | (0.1) | (0.0) | 0.1 | 0.0 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 | (0.0) |
| Net Income | ||||||||||||||||
| Net Income | (0.0) | (1.2) | 4.7 | (7.3) | (5.3) | 0.5 | 0.4 | (2.1) | 0.1 | (1.5) | (6.9) | (10.4) | (13.1) | (7.4) | (6.3) | (8.7) |
| Per Share | ||||||||||||||||
| Basic EPS | — | (0.08) | 0.34 | (0.54) | (0.39) | 0.04 | 0.03 | (0.18) | 0.01 | — | — | (1.20) | (2.20) | — | — | — |
| Diluted EPS | — | (0.08) | 0.33 | (0.54) | (0.39) | 0.04 | 0.02 | (0.18) | 0.01 | — | — | (1.20) | (2.20) | — | — | — |
| Basic Weighted Avg Shares | — | 13.8 | 13.7 | 13.5 | 13.5 | 13.2 | 13.1 | 11.8 | 11.3 | — | — | 8.7 | 6.0 | — | — | — |
| Diluted Weighted Avg Shares | — | 13.8 | 14.3 | 13.5 | 13.5 | 14.2 | 14.6 | 11.8 | 14.1 | — | — | 8.7 | 6.4 | — | — | — |
| Supplemental | ||||||||||||||||
| EBITDA | — | 0.2 | 6.2 | (5.5) | (3.0) | 2.2 | 1.6 | (1.1) | 0.9 | (1.0) | (6.6) | (10.2) | (13.0) | (6.0) | — | — |
| EBIT | (1.1) | (1.1) | 4.6 | (7.4) | (5.3) | 0.6 | 0.4 | (1.9) | 0.3 | (1.4) | (6.8) | (10.3) | (13.2) | (6.3) | (6.2) | (9.1) |
| Effective Tax Rate | -26.5% | — | — | — | -1.3% | 6.0% | 17.2% | -6.6% | 44.6% | -2.3% | -0.3% | -0.9% | -1.0% | -0.2% | -0.2% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.